AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2008
Dec 5, 2008
33510_dirs_2008-12-05_5b7404e9-ca85-4c17-9e9e-3f96e8afc8ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2008-11-26
Reporting Person: Smith Albert Louis (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-11-26 | Common Stock | P | 27264 | $0.2467 | Acquired | 149411 | Direct |
| 2008-11-26 | Common Stock | P | 13690 | $0.2546 | Acquired | 163101 | Direct |
| 2008-11-26 | Common Stock | P | 17100 | $0.26 | Acquired | 180201 | Direct |
| 2008-11-26 | Common Stock | P | 17900 | $0.2629 | Acquired | 198101 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16